89 related articles for article (PubMed ID: 25033564)
1. [Insulin potentiating and antidepressant effects of 3-oxypyridine and succinic acid derivatives].
Volchegorskiĭ IA; Miroshnichenko IIu; Rassokhina LM; Faĭzullin RM
Eksp Klin Farmakol; 2014; 77(5):6-9. PubMed ID: 25033564
[TBL] [Abstract][Full Text] [Related]
2. [Antidepressant effect of 3-oxypyridine and succinic acid derivatives (experimental study)].
Volchegorskii IA; Miroshnichenko IY; Rassokhina LM; Malkin MP; Faizullin RM; Pryakhina KE; Kalugina AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(2):48-52. PubMed ID: 26081324
[TBL] [Abstract][Full Text] [Related]
3. [Anxiolytic and antidepressant effects of 3-oxypiridine and succinic acid derivatives in the acute phase of alloxan-induced diabetes in rats].
Volchegorskiĭ IA; Miroshnichenko IIu; Rassokhina LM; Faĭzullin RM; Malkin MP; Priakhina KE; Kalugina AV
Eksp Klin Farmakol; 2014; 77(4):14-20. PubMed ID: 25076754
[TBL] [Abstract][Full Text] [Related]
4. [Anxiolytic and antidepressant effects of emoxipine, reamberin and mexidol in experimental diabetes mellitus].
Volchegorskii IA; Miroshnichenko IY; Rassokhina LM; Faizullin RM; Pryakhina KE
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):52-57. PubMed ID: 28638031
[TBL] [Abstract][Full Text] [Related]
5. [Anxiolytic and antidepressant effects of 3-oxypiridine and succinic acid derivatives in alloxan diabetes].
Volchegorskii LA; Miroshnichenko IY; Rassokhina LM; Faizullin RM; Pryakhina KE; Kalugina AV
Ross Fiziol Zh Im I M Sechenova; 2015 Mar; 101(3):258-67. PubMed ID: 26016320
[TBL] [Abstract][Full Text] [Related]
6. [ANTIANHEDONIC EFFECT OF 3-OXYPYRIDINE AND SUCCINIC ACID DERIVATIVES].
Volchegorskii IA; Miroshnichenko IY; Rassokhina LM; Faizullin RM; Pryakhina KE
Ross Fiziol Zh Im I M Sechenova; 2016 Nov; 102(11):1312-22. PubMed ID: 30193447
[TBL] [Abstract][Full Text] [Related]
7. [Cerebroprotective effect of 3-oxypyridine and succinic acid derivatives in acute phase of alloxan-induced diabetes mellitus in rats].
Volchegorskiĭ IA; Rassokhina LM; Miroshnichenko IIu
Eksp Klin Farmakol; 2011; 74(5):17-25. PubMed ID: 21809693
[TBL] [Abstract][Full Text] [Related]
8. [The effect of 3-oxypyridine and succinic acid derivatives on obsessive-compulsive activity of mice in marble-burying test].
Volchegorskiĭ IA; Miroshnichenko IIu; Rassokhina LM; Faĭzullin RM; Priakhina KE
Eksp Klin Farmakol; 2014; 77(10):10-4. PubMed ID: 25518521
[TBL] [Abstract][Full Text] [Related]
9. [Cerebroprotective effect of 3-oxypyridine and succinic acid derivatives in experimental diabetes mellitus].
Volchegorskiĭ IA; Rassokhina LM; Miroshnichenko IIu
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(6):50-61. PubMed ID: 23887452
[TBL] [Abstract][Full Text] [Related]
10. [Protective effect of 3-oxypyridine and succinic acid derivatives under conditions of acute alloxan-induced intoxication in mice].
Volchegorskiĭ IA; Miroshnichenko IIu; Rassokhina LM; Malkin MP; Maĭzyllin RM; Priakhina KE; Kalugina AV
Eksp Klin Farmakol; 2014; 77(1):13-6. PubMed ID: 24649596
[TBL] [Abstract][Full Text] [Related]
11. [Antihypoxic effect of 3-hydroxypyridine and succinic acid derivatives and their nootropic action in alloxan diabetes].
Volchegorskiĭ IA; Rassokhina LM; Miroshnichenko IIu
Eksp Klin Farmakol; 2011; 74(12):27-32. PubMed ID: 22379879
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of the anxiolytic effects of 3-hydroxypyridine and succinic acid derivatives.
Volchegorskii IA; Miroshnichenko IY; Rassokhina LM; Faizullin RM; Malkin MP; Pryakhina KE; Kalugina AV
Bull Exp Biol Med; 2015 Apr; 158(6):756-61. PubMed ID: 25894772
[TBL] [Abstract][Full Text] [Related]
13. [Experimental study of 3-oxypiridine and succinic acid derivates antidepressant activity in mice].
Volchegorskiĭ IA; Miroshnichenko IIu; Rassokhina LM; Faĭzullin RM
Eksp Klin Farmakol; 2013; 76(7):6-10. PubMed ID: 24006608
[TBL] [Abstract][Full Text] [Related]
14. [The effect of 3-oxypyridine and succinic acid derivatives on the resistance to acute cerebral ischemia].
Volchegorskiĭ IA; Miroshnichenko II; Rassokhina LM; Faĭzullin RM; Priakhina KE; Malkin MP; Kalugina AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(12):123-127. PubMed ID: 25726791
[TBL] [Abstract][Full Text] [Related]
15. [Dopaminergic potential of domestic 3-hydroxypyridine and succinic acid derivatives and prospects for their therapeutic «retargeting»].
Volchegorskii IA; Rassokhina LM; Miroshnichenko IU
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(8):21-29. PubMed ID: 37655406
[TBL] [Abstract][Full Text] [Related]
16. [Possibilities of «therapeutic retargeting» of 3-hydroxypyridine and succinic acid derivatives due to their dopaminergic action].
Volchegorskii IA; Rassokhina LM; Miroshnichenko IU
Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(3):17-26. PubMed ID: 38529859
[TBL] [Abstract][Full Text] [Related]
17. Cerebroprotective effects of emoxipin, reamberin, and mexidol in alloxan diabetes.
Volchegorskii IA; Rassokhina LM; Miroshnichenko IY
Bull Exp Biol Med; 2013 May; 155(1):56-64. PubMed ID: 23667872
[TBL] [Abstract][Full Text] [Related]
18. [Effect of 3-oxypyridine and succinic acid derivatives on affective status in recrudescence of inflammatory diseases of uterus and its appendages].
Volchegorskiĭ IA; Pravdin EV; Uzlova TV
Eksp Klin Farmakol; 2012; 75(11):22-7. PubMed ID: 23323329
[TBL] [Abstract][Full Text] [Related]
19. Effects of 3-hydroxypyridine derivatives and succinic acid on endometrial leukocyte infiltration, cytokinemia and related affective symptoms during exacerbation of the chronic inflammation of the uterus and adnexa.
Volchegorskii IA; Pravdin EV; Uzlova TV
Bull Exp Biol Med; 2014 Jan; 156(3):347-52. PubMed ID: 24771373
[TBL] [Abstract][Full Text] [Related]
20. [Antidepressant action of emoxipin and mexidol in mice with alloxan diabetes].
Volchegorskiĭ IA; Rassokhina LM; Miroshnichenko IIu
Eksp Klin Farmakol; 2009; 72(2):11-5. PubMed ID: 19441720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
